Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10424628 | 0.95 | CYP3A4 (0.38) | KMT2AHPGDTHRBGSTP1TAAR1 | |
| SCHEMBL5137766 | 0.87 | CYP3A4 (0.41) | KMT2AHPGDALDH1A1SMN1; SMN2CYP3A4 | |
| SCHEMBL16648981 | 0.85 | KMT2A (0.44) | KMT2AHPGDTHRBTAAR1ALDH1A1 | |
| SCHEMBL8170012 | 0.84 | GSTP1 (0.46) | KMT2AHPGDTHRBGSTP1TAAR1 | |
| SCHEMBL28580465 | 0.81 | TSHR (0.47) | KMT2AHPGDTHRBTAAR1ALDH1A1 | |
| SCHEMBL4767012 | 0.80 | KMT2A (0.40) | KMT2AHPGDGSTP1TAAR1ALDH1A1 | |
| SCHEMBL472103 | 0.79 | ALDH1A1 (0.47) | KMT2AHPGDTHRBGSTP1ALDH1A1 | |
| SCHEMBL6964301 | 0.78 | ALDH1A1 (0.40) | HPGDTHRBGSTP1TAAR1ALDH1A1 | |
| SCHEMBL8693254 | 0.78 | ALDH1A1 (0.46) | KMT2AHPGDTHRBGSTP1ALDH1A1 | |
| SCHEMBL28820040 | 0.78 | ALDH1A1 (0.46) | KMT2AHPGDTHRBGSTP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8664414-B2 | Process for producing epoxy compound | SHOWA DENKO K.K. (JP) | 2014-03-04 | — | — | US | disclosed |
| US-8466303-B2 | Process for production of epoxy compound | SHOWA DENKO K.K. (JP) | 2013-06-18 | — | — | US | disclosed |
| US-20120029217-A1 | PROCESS FOR PRODUCING EPOXY COMPOUND | SHOWA DENKO K.K. (JP) | 2012-02-02 | — | — | US | disclosed |
| EP-2412712-A1 | METHOD FOR PRODUCING EPOXY COMPOUND | Showa Denko K.K. (JP) | 2012-02-01 | — | — | EP | disclosed |
| US-20110009652-A1 | PROCESS FOR PRODUCTION OF EPOXY COMPOUND | SHOWA DENKO KK (JP) | 2011-01-13 | — | — | US | disclosed |
| EP-2261219-A1 | PROCESS FOR PRODUCTION OF EPOXY COMPOUND | Showa Denko K.K. (JP) | 2010-12-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120029217-A1 | PROCESS FOR PRODUCING EPOXY COMPOUND | NOX4, NOX5, NOXO1 | KMT2A 1235/4885HPGD 263/4885THRB 4769/4885 |
| US-20110009652-A1 | PROCESS FOR PRODUCTION OF EPOXY COMPOUND | DUOX2, EPX, DUOX1 | KMT2A 1160/4885HPGD 90/4885THRB 4353/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.